Literature DB >> 15170407

Structure and function of beta3-adrenergic receptors.

Vytenis Arvydas Skeberdis1.   

Abstract

Beta-adrenergic receptors have been subdivided into three types: beta1-, beta2- and beta3-adrenergic receptors. beta1-adrenergic receptors are predominant in the heart, beta2-adrenergic receptors--in the respiratory system, and beta3-adrenergic receptors--in the adipose tissues. However, since 1989, when beta3-adrenergic receptor was cloned, numerous biochemical and functional studies have confirmed its presence in various species and tissues, including the heart. Unlike beta1- and beta2-adrenergic receptors, it has been shown that beta3-adrenergic receptors possess the cardiodepressant effects in human ventricles, what did not fit to its stimulatory properties of adenylyl cyclase in other tissues. In this regard, the role of beta3-adrenergic receptors in the regulation of cardiac function may be of great importance in pathological conditions and remains undetermined, so far. In this review brief characterization of beta3-adrenergic receptors, concerning their structure, function and possible pathophysiological role is provided.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15170407

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  14 in total

Review 1.  Cytokine-Ion Channel Interactions in Pulmonary Inflammation.

Authors:  Jürg Hamacher; Yalda Hadizamani; Michèle Borgmann; Markus Mohaupt; Daniela Narcissa Männel; Ueli Moehrlen; Rudolf Lucas; Uz Stammberger
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

2.  Mirabegron Toxicosis in Dogs: a Retrospective Study.

Authors:  Renee D Schmid; Lynn R Hovda
Journal:  J Med Toxicol       Date:  2017-12-18

3.  beta-Adrenergic activation of electrogenic K+ and Cl- secretion in guinea pig distal colonic epithelium proceeds via separate cAMP signaling pathways.

Authors:  Susan T Halm; Jin Zhang; Dan R Halm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-22       Impact factor: 4.052

4.  Adrenergic activation of electrogenic K+ secretion in guinea pig distal colonic epithelium: desensitization via the Y2-neuropeptide receptor.

Authors:  Jin Zhang; Susan T Halm; Dan R Halm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-04       Impact factor: 4.052

5.  ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.

Authors:  Maha Daghestani; Mazin Daghestani; Mamoon Daghistani; Abdelmoneim Eldali; Zeinab K Hassan; Maha H Elamin; Arjumand Warsy
Journal:  Lipids Health Dis       Date:  2018-03-27       Impact factor: 3.876

6.  Adrenergic activation of electrogenic K+ secretion in guinea pig distal colonic epithelium: involvement of beta1- and beta2-adrenergic receptors.

Authors:  Jin Zhang; Susan T Halm; Dan R Halm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-05-21       Impact factor: 4.052

7.  ROCK inhibitor is not required for embryoid body formation from singularized human embryonic stem cells.

Authors:  Giuseppe Pettinato; Wendy S Vanden Berg-Foels; Ning Zhang; Xuejun Wen
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 8.  Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.

Authors:  Jasmina Varagic; Henry Punzi; Carlos M Ferrario
Journal:  Integr Blood Press Control       Date:  2014-11-26

Review 9.  Targeting β3-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade.

Authors:  Alessandro Cannavo; Walter J Koch
Journal:  J Cardiovasc Pharmacol       Date:  2017-02       Impact factor: 3.105

10.  Adrenergic β2-receptors mediates visceral hypersensitivity induced by heterotypic intermittent stress in rats.

Authors:  Chunhua Zhang; Yun-Yun Rui; Yuan-Yuan Zhou; Zhong Ju; Hong-Hong Zhang; Chuang-Ying Hu; Ying Xiao; Guang-Yin Xu
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.